Compounds > 3,3',4,5'-tetrahydroxystilbene
Page last updated: 2024-08-16

3,3',4,5'-tetrahydroxystilbene and Lymphoma, Non-Hodgkin

3,3',4,5'-tetrahydroxystilbene has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alas, S; Bonavida, B1

Other Studies

1 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Lymphoma, Non-Hodgkin

ArticleYear
Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; bcl-X Protein; Carrier Proteins; Cytokines; DNA Fragmentation; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Humans; Immunoblotting; Interleukin-10; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Lymphoma, Non-Hodgkin; Models, Biological; Multiple Myeloma; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor; Stilbenes; Time Factors; Trans-Activators; Tumor Cells, Cultured; Tyrphostins; Vinblastine

2003